How Investors May Respond To Pacira BioSciences (PCRX) Activist Pressure Amid Buybacks And Rising EXPAREL Revenue [Yahoo! Finance]
Pacira BioSciences, Inc. (PCRX)
Last pacira biosciences, inc. earnings: 2/20 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.pacira.com
Company Research
Source: Yahoo! Finance
On top of record EXPAREL volume growth, the company now faces pressure from activist DOMA Perpetual Capital Management, which is pushing for board changes and a potential sale process. With Pacira pairing strong preliminary EXPAREL-driven revenue with an aggressive share repurchase program, we'll now examine how this reshapes its investment narrative. The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 28 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement. To own Pacira, you need to be comfortable with a business still anchored to a single flagship product, EXPAREL, while it works to broaden its portfolio and improve profitability. The preliminary 2025 revenue uptick, record EXPAREL volumes, and large buyback support that core thesis, but the immediate spotlight now falls on the activist campa
Show less
Read more
Impact Snapshot
Event Time:
PCRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PCRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PCRX alerts
High impacting Pacira BioSciences, Inc. news events
Weekly update
A roundup of the hottest topics
PCRX
News
- Do Options Traders Know Something About Pacira BioSciences Stock We Don't? [Yahoo! Finance]Yahoo! Finance
- Pacira Announces Agreement with LG Chem to Make EXPAREL® Available in Select Asian-Pacific MarketsGlobeNewswire
- Pacira BioSciences (NASDAQ:PCRX) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $30.00 price target on the stock.MarketBeat
- Pacira BioSciences (NASDAQ:PCRX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.MarketBeat
- Pacira drops after adjusting 2025 revenue below consensus [Seeking Alpha]Seeking Alpha
PCRX
Earnings
- 11/6/25 - Beat
PCRX
Sec Filings
- 1/9/26 - Form DFAN14A
- 1/8/26 - Form 8-K
- 1/6/26 - Form 4
- PCRX's page on the SEC website